AXL and inflammatory breast carcinoma: TIG1 and Axl expression are positively correlated in primary IBC patient tissues, and the binding of TIG1 to Axl inhibits the proteasome-dependent degradation of Axl and supports the Axl signaling pathway in IBC cells [14].